leisure time -WSS

leisure time

author：hotspot 2025-09-01 05:55:29 - browse：8

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8 billion saga will finally draw to a close this month.

Shares in the newly independent Grail are expected to be distributed on June 24, Illumina said in a statement. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL.

It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina turned it into an independent company the following year but then agreed to reacquire it for $8 billion in September 2020.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Clinic falsely told dozens they had Alzheimer's, suits say

knowledge

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Americans' trust in science, scientist continues decline: Report

New requirements coming in 2024 for Americans traveling to Europe

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

4 missing after record

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Alkermes shareholders re

FAMU bans football players from facility after release of rap video shot in team's locker room

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The response to Covid

Medicare proposal to cover medical devices draws a mixed reaction

In diabetes hearing, Sanders takes on a new foe: food makers

In age of alternative facts, a scholarly course on calling out crap

Americans' trust in science, scientist continues decline: Report

Hollywood unions extend contract negotiations for actors

4 missing after record

explore

How to protect coverage of PrEP

What Henrietta Lacks's story taught me about my role as a doctor

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Sophia Smith scores twice for US in in 3

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

FDA needs staff influx to meet gene therapy needs, Marks says

explore

hotspot

knowledge

entertainment